However, low RASSF10 expression was more likely in HCC patients with tumor thrombus (P = 0.001, odds ratio (OR) = 0.119, 95% confidence interval (CI): 0.036-0.397) and hepatocirrhosis (P < 0.001, OR = 0.321, 95% CI: 0.181-0.572). This evidence concerns the gene RASSF10 and hepatocellular carcinoma.